The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Mechanisms of resistance to anti-PD1 treatment in recurrent and/or metastatic squamous cell carcinoma of the head and neck: A multi-omics IMMUCAN/EORTC analysis.
 
Athenais van der Elst
No Relationships to Disclose
 
Daniel Herrero Saboya
Research Funding - Institut de Recherches Servier
 
Lucas Michon
No Relationships to Disclose
 
Marie Morfouace
Employment - Merck KGaA
 
Robin Liechti
No Relationships to Disclose
 
Daniel Schulz
No Relationships to Disclose
 
Maya Persoons
No Relationships to Disclose
 
Sylvie Rusakiewicz
No Relationships to Disclose
 
Marie-Sophie Robert
No Relationships to Disclose
 
Henoch Hong
Employment - Merck KGaA
 
Rachel Galot
Speakers' Bureau - BMS (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo/Lilly; MSD; MSD; MSD Oncology
 
Paolo Bossi
Honoraria - Angelini; BeiGene; Daiichi-Sankyo; Genmab/Seagen; GlaxoSmithKline; Merck; Merus; MSD Oncology; Pfizer; Regeneron; Sun Pharma
Consulting or Advisory Role - Angelini Pharma; Daiichi-Sankyo; Genmab/Seagen; GlaxoSmithKline; Merck Serono; MSD Oncology; Nutricia; Sanofi/Regeneron; Sun Pharma
Research Funding - BeiGene (Inst); GlaxoSmithKline (Inst); Merck Serono (Inst); MSD Oncology (Inst); Regeneron (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Merck Serono
 
Florian Estrade
No Relationships to Disclose
 
Julio Oliveira
Consulting or Advisory Role - GlaxoSmithKline; Novartis; Roche
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen Oncology; Novartis
 
Caroline Even
Consulting or Advisory Role - Bristol-Myers Squibb; Fstar Therapeutics (Inst); GlaxoSmithKline (Inst); Innate Pharma; Merck Serono; Merus (Inst); MSD Oncology; Novartis (Inst)
Travel, Accommodations, Expenses - Merck Serono; Merck Serono; MSD Oncology
 
Sophie Lucas
No Relationships to Disclose
 
Pierre Saintigny
Honoraria - Archer; Bristol Myer Squibb; HTG Molecular Diagnostics; Inivata; Roche Molecular Diagnostics
Research Funding - AstraZeneca; BMS Foundation; Illumina; Novartis; Omicure (Inst); Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol Myer Squibb; Illumina; Roche
 
Céline Lefebvre
Employment - Institut de Recherches Servier
 
Loredana Martignetti
No Relationships to Disclose
 
Jean-Pascal Machiels
Consulting or Advisory Role - ALX Oncology; ANAVEON (Inst); Astellas Pharma (Inst); AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; CUE Biopharma; CureVac (Inst); eTHERNA; F-star; Genmab (Inst); GlaxoSmithKline (Inst); Incyte; Innate Pharma; IPSEN (Inst); ITeos Therapeutics; Janssen; Merck Serono; Merus (Inst); MSD Oncology (Inst); NEKTAR; Novartis; Pfizer; Roche; Seagen (Inst); Seagen (Inst)
Research Funding - Bayer; Janssen; Novartis; Sanofi
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Gilead Sciences; Merck Serono (Inst); MSD; Pfizer
Other Relationship - PsiOxus Therapeutics